InvestorsHub Logo
Followers 30
Posts 2790
Boards Moderated 3
Alias Born 10/24/2015

Re: creakyhottie post# 17

Wednesday, 01/20/2021 10:29:16 PM

Wednesday, January 20, 2021 10:29:16 PM

Post# of 75
Both lead assets (AUTO1 and AUTO3) have shown promising data to date, with best-in-class potential. I know they are now looking to partner the latter, and for the former, AUTO1 could see approval in 2022 (aALL).

Other assets, including AUTO4/5 (both in T-cell lymphoma's), AUTO6NG (in select GD2+ solid tumours), and AUTO7 (mCRPC) are also promising.

So I have a long-term position.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AUTL News